On September 10, 2026 Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company focused on the development of novel oral therapeutics, reported that Company management will present and meet with investors at the H.C. Wainwright 28th Annual Global Investment Conference, to be held in person and virtually September 14-16, 2026.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details

Date:

Wednesday, September 16, 2026

Time:

10am ET

Location:

New York, NY

Investors can register for the conference here. Those interested in arranging a one-on-one meeting with Lipocine should contact their H.C. Wainwright representative.

The live webcast and subsequent replay of the presentation can be accessed in the "Events" section of Lipocine’s website after the presentation. The webcast will be archived and available for 90 days following the live event.

(Press release, Lipocine, SEP 10, 2026, View Source [SID1234670720])